The Global Cannabis based epilepsy drugs Market Size is set to register impressive CAGR of 46% during the forecast period to create high incremental opportunity for industry players. Expected FDA approval of first ever marijuana based drug – Epidiolex will revolutionize the healthcare industry. Many new players might emerge in the market citing high lucrative revenue opportunity.

The Global Antifungal Drugs Market is estimated to be valued over 11 billion in 2018. Product development and strategic distribution network are the key strategic focus of the most of the companies operating in the segment. Some key antifungal drugs industry players are Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., Novartis AG, Pfizer, Inc.,

Global pediatric mechanical heart valve market is expected to register a CAGR of 11.9% to create high revenue opportunity for industry players. Recently, in 2018, Abbott received USFDA approval for its product – Masters HP™ 15mm rotatable mechanical heart valve – to treat toddlers in need of aortic replacement valve. Similar such developments will be visible during the forecast period

The Global Drug Eluting Stents Market Size is estimated to be valued over USD 6.4 billion in 2018 with CAGR of 5.9% during the forecast period, 2018 – 2028. The industry is highly competitive with top five players accounting for over 85% of the market share. Fierce competition has led to a complete change in overall industry dynamics.

The Global Medical Imaging Market Size is estimated to be valued over USD 33 billion in 2018.
The industry will register robust growth in developing regions despite a hardened stance on regulatory and pricing part. Sustained macroeconomic growth along with demand for early diagnosis of chronic illness will create favorable medical imaging market growth worldwide

The Global Minimally Invasive Benign Prostatic Hyperplasia (BPH) Therapy Devices Market Size is estimated to be valued over USD 426 million in 2018 with CAGR of 3.9% during the forecast period, 2018 – 2028. The industry is highly consolidated with top five players accounting for over 85% of market share in 2017.

The Global Oral Contraceptives Pills Market Size is estimated to be valued over USD 16 billion in 2018. Government initiated programs and the need to stop unintended pregnancy has led to wide scale adoption of these pills worldwide. Lately, the industry has registered robust growth with advancement in South East Asia owing to various factors.